Mary Ann Liebert: Machine Learning Model to Predict the Fitness of AAV Capsids for Gene Therapy
April 19, 2025
April 19, 2025
NEW ROCHELLE, New York, April 19 -- Mary Ann Liebert Inc. issued the following news release:
* * *
Machine Learning Model to Predict the Fitness of AAV Capsids for Gene Therapy
New Rochelle, NY, April 17, 2025--A new study in the peer-reviewed journal Human Gene Therapy describes a machine learning (ML) model that can be used as a surrogate for laborious in vitro experiments. This in silico approach aims to increase the fitness of clinical adeno-associated . . .
* * *
Machine Learning Model to Predict the Fitness of AAV Capsids for Gene Therapy
New Rochelle, NY, April 17, 2025--A new study in the peer-reviewed journal Human Gene Therapy describes a machine learning (ML) model that can be used as a surrogate for laborious in vitro experiments. This in silico approach aims to increase the fitness of clinical adeno-associated . . .